A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286.
Javier G Pizarro, Jaume Folch, José Luis Esparza, J Jordan, Mercè Pallàs, Antoni Camins
Index: J. Cell. Mol. Med. 13(9B) , 3906-17, (2009)
Full Text: HTML
Abstract
Pharmacological GSK-3 inhibitors are potential drugs for the treatment of neurodegenerative diseases, cancer and diabetes. We examined the antiproliferative effects of two GSK-3 inhibitors, lithium and SB-415286, on B65 neuroblastoma cell line. Treatment of B65 cells with either drug administered separately caused a decrease in cell proliferation that was associated with G(2)/M cell cycle arrest. Cell-cycle proteins such as cyclins D, E, A, cdk4 and cdk2 were up-regulated. Since lithium and SB-415286-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically cyclin B, cdc2 and the phosphorylated form of this protein (tyr15-cdc2). Both drugs increased the expression of tyr15-cdc2, thus inhibiting mitosis. On the other hand, SB-415286 increased the expression of SIRT2, involved in the regulation of proliferation. Moreover, cell-cycle arrest mediated by SB-415286 was accompanied by apoptosis that was not prevented by 100 microM of zVAD-fmk (benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone), a pan-caspase inhibitor. Likewise, GSK-3 inhibitors did not affect the mitochondrial release of apoptosis inducing factor (AIF). We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of cdc2 and, in the case of SB-415286, SIRT2 expression, which induced apoptosis in a caspase-independent manner.
Related Compounds
Related Articles:
2014-10-01
[Br. J. Dermatol. 171(4) , 742-53, (2014)]
Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS.
2008-09-03
[J. Neurosci. 28(36) , 8914-28, (2008)]
Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta.
2006-03-01
[Br. J. Pharmacol. 147(5) , 575-82, (2006)]
2003-09-01
[Eur. J. Biochem. 270(18) , 3829-38, (2003)]
GSK-3 inhibitors induce chromosome instability.
2007-01-01
[BMC Cell Biol. 8 , 34, (2007)]